瓦尔酸相关的高氨性脑病变与普遍抑制EEG:一个病例报告
1The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
概括
瓦尔酸相关的高氨性脑病变 (VHE) 可以导致普遍的EEG抑制模式,模仿不良预后. 及时识别和VHE管理对于患者的康复至关重要.
科学领域:
- 神经科学是一个神经科学.
- 临床神经学 临床神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 酸 (VPA) 是一种常见的抗发作药物 (ASM).
- 瓦尔酸相关的高氨性脑病变 (VHE) 是VPA治疗的罕见并发症.
- 典型的VHEEEG发现包括分散的缓慢或周期波,但不是普遍的抑制.
研究的目的:
- 报告一种VHE病例,呈现出一种普遍的EEG抑制模式.
- 要突出认识到这种非典型的EEG呈现在VHE中的重要性.
- 要强调的是,这种模式并不一定表明预后不好.
主要方法:
- 一个29岁的女性患有,接受VPA治疗的病例报告.
- 持续的EEG监测和血液氨水平评估.
- 通过停止VPA和启动oxcarbazepine来调整治疗.
主要成果:
- 患者的意识受到损害,并出现了普遍的EEG抑制模式.
- 显著升高的血氨水平 (386.8μmol/L) 证实了VHE.
- 停止使用VPA和过渡到oxcarbazepine导致EEG正常化和恢复意识.
结论:
- VHE可以表现为一种普遍的EEG抑制模式.
- 在VHE中这种EEG模式不应该被误解为预后不佳的迹象.
- 早期发现和适当管理VHE对于神经恢复至关重要.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
221
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
221
Antiepileptic Drugs: Glutamate Antagonists
435
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
435
Antiepileptic Drugs: GABAergic Pathway Potentiators
474
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
474
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
354
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
354
Epilepsy and Seizures: Overview
230
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
230
Seizures: Classification
451
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
451


